Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micafungin for preventing invasive mycosis after liver transplantation
NCT04728971Phase 4Not yet recruiting
- Sponsor
- Shanghai General Hospital
- Start
- Oct 2022
- Primary completion
- Oct 2025
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of micafungin in invasive mycosis, sponsored by Shanghai General Hospital. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
micafungin
03
Conditions
invasive mycosis
Beyond the preview
Go deeper on NCT04728971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04728971.